Aktiesnakken — April 2011
-
TOPO: HDAC mot HIV nu i klinisk studie! http://clinicaltrials.gov/ct2/show/NCT01319383
-
Repower: Suzlon på vej med fuld overtagelse
-
TOPO: HDAC och HIV, ny artikel: http://www.molmed.org/content/papers in press/11_76_Matalon.pdf
-
greentech offentliggøre statusrapport fra deres italienske advokater vedr. Messina
-
-
der står vel egentlig ikke det store, udover at retten nu afventer anklagerens kommentarer til det hele
-
og at greentechs advokater har talt med anklageren mange gange og fremført/forhandlet GES' sag
-
-
atlantic: 68000 tønder i marts
-
2194 boe per day. Chestnut is currently producing at a reduced rate due to water injection constraints.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind